Stay updated on Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial
Sign up to get notified when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.

Latest updates to the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded Revision: v3.4.2. The prior funding-status notice and Revision: v3.4.1 were removed.SummaryDifference0.5%

- Check34 days agoChange DetectedAdded a government funding notice noting potential delays in updates and the NIH Clinical Center's status, with guidance to check cc.nih.gov and opm.gov. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page now includes a glossary toggle and new metadata fields: Last Update Submitted that Met QC Criteria and Last Update Posted, along with a revision indicator: Revision: v3.4.0. Older items Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.3%

- Check55 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3 in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded a Locations section with California listed and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check98 days agoChange DetectedThe page shows a revision update from v3.3.1 to v3.3.2; there is no change to the study content, eligibility, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.